Project Details
Description
DEVELOPMENT OF SPECIFIC INHIBITORS FOR BREAST CANCER-ASSOCIATED VARIANTS OF ERBB2
| Status | Finished |
|---|---|
| Effective start/end date | 09/26/14 → 09/25/18 |
Funding
- US Army Medical Research Acquisition Activity: $243,243.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.